These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6136639)

  • 1. Agents for the treatment of heart failure.
    Bristol JA; Evans DB
    Med Res Rev; 1983; 3(3):259-87. PubMed ID: 6136639
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategy for the discovery and development of a positive inotropic agent.
    Evans DB; Weishaar RE; Kaplan HR
    Pharmacol Ther; 1982; 16(3):303-30. PubMed ID: 6127729
    [No Abstract]   [Full Text] [Related]  

  • 3. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 4. Inotropic drugs in the treatment of heart failure.
    Scholz H
    Hosp Pract (Off Ed); 1984 May; 19(5):57-67, 70-1. PubMed ID: 6143760
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cardiac insufficiency with cardiac glycosides].
    Tsyganiĭ AA; Rudenko AF; Kovalev NL; Malinovskiĭ OP; Koziar VV
    Vrach Delo; 1980 Aug; (8):60-3. PubMed ID: 7415132
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological aspects on the treatment of CHF.
    Andersson KE
    Acta Med Scand Suppl; 1981; 652():69-91. PubMed ID: 6120616
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative pharmacology of cardiac and vascular tissues in heart failure.
    Godfraind T
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S1-20. PubMed ID: 2483434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biphasic action of cardiac glycosides on the Na+, K+-pump and its relevance in the treatment of heart failure.
    Godfraind T
    Eur Heart J; 1982 Dec; 3 Suppl D():53-7. PubMed ID: 6297911
    [No Abstract]   [Full Text] [Related]  

  • 9. Congestive heart failure. An overview of drug therapy.
    Horwitz LD
    Postgrad Med; 1984 Aug; 76(2):187-90, 192-3. PubMed ID: 6146965
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate.
    Movsesian MA
    J Am Coll Cardiol; 1999 Aug; 34(2):318-24. PubMed ID: 10440139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of congestive heart failure.
    Sjögren A
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():93-101. PubMed ID: 6369885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do beta-blockers improve ventricular function in patients with congestive heart failure?
    Barry WH; Gilbert EM
    Circulation; 2003 May; 107(19):2395-7. PubMed ID: 12756189
    [No Abstract]   [Full Text] [Related]  

  • 13. New and old inotropic drugs: controversies and challenges, Oslo, Norway, May 21-22, 1982: reflections on inotropic drugs: a personal commentary.
    Storstein L; Taylor SH
    Clin Cardiol; 1984 Feb; 7(2):119-24. PubMed ID: 6142780
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
    Canepa-Anson R; Dawson JR; Frankl WS; Kuan P; Sutton GC; Reuben S; Poole-Wilson PA
    Eur Heart J; 1982 Dec; 3 Suppl D():129-34. PubMed ID: 6130946
    [No Abstract]   [Full Text] [Related]  

  • 15. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Adonis pseudoamuensis W. T. Wang on cardiac function].
    Chi LG; Chen Z; Chen Y
    Yao Xue Xue Bao; 1988 Feb; 23(2):91-5. PubMed ID: 3188926
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
    Port JD; Gilbert EM; Larrabee P; Mealey P; Volkman K; Ginsburg R; Hershberger RE; Murray J; Bristow MR
    Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new inotropic drugs.
    Carlier J; el Allaf D
    Resuscitation; 1984 Mar; 11(3-4):217-31. PubMed ID: 6144152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of left ventricular contraction period determination by the polygraphic method in the treatment of patients with overt circulatory failure by means of administering cardiac glycosides].
    Smielak-Korombel W
    Pol Tyg Lek; 1976 Sep; 31(38):1641-4. PubMed ID: 980985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.